CRISPR Gene Editing in 2026: Rewriting the Code of Life
Casgevy, the first-ever CRISPR medicine, has now been approved in 10+ countries. 100% of sickle cell patients in its trial achieved freedom from crises. 98.2% of beta-thalassaemia patients achieved transfusion…
Olu Mide
